Sonnet BioTherapeutics Provides Fiscal Year 2023 Business and Financial Update
PRINCETON, NJ / ACCESSWIRE / December 14, 2023 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical...
Clinical Trial
Hope On The Horizon: Tonix Pharmaceuticals (NASDAQ:TNXP) Could Be On the Cusp of Changing Fibromyalgia Treatment Options With TNX-102 SL
Topline Data from a Registration-Enabling Phase 3 Clinical Trial is Due Later This Month.CHATHAM, NJ / ACCESSWIRE / December 14,...
Glaukos Announces FDA Approval of iDose® TR (travoprost intracameral implant)
Revolutionary, micro-invasive, injectable treatment for the full range of glaucoma disease severity iDose TR was designed to usher in a...
Applied DNA Announces Joint Development Agreement to Integrate Linea(TM) IVT Platform into CDMO Kudo Biotechnology’s mRNA Manufacturing Workflow
- Agreement Seeks to Leverage Linea IVT Platform to Enable Kudo Bio to Offer a Differentiated mRNA Manufacturing Capability with...
Moderna And Merck Announce mRNA-4157 (V940) In Combination with Keytruda(R) (Pembrolizumab) Demonstrated Continued Improvement in Recurrence-Free Survival and Distant Metastasis-Free Survival in Patients with High-Risk Stage III/IV Melanoma Following Complete Resection Versus Keytruda at Three Years
At a median planned follow-up of approximately three years, mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence...
Ambrx to be Added to the NASDAQ Biotechnology Index (NBI)
SAN DIEGO, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma, Inc., or Ambrx, (NASDAQ: AMAM), today announced that the Company...
Clene Announces Peer-Reviewed Publication Describing CNM-Au8 Brain Target Engagement In Neurodegenerative Diseases
Journal of Nanobiotechnology publication describes results from the successful Phase 2 REPAIR clinical studies that measured changes in brain energy...
ASTCT Response to FDA Approval of Gene Therapies for Treatment of Sickle Cell Disease (SCD)
CHICAGO, IL / ACCESSWIRE / December 13, 2023 / The American Society for Transplantation and Cellular Therapy® (ASTCT®) recognizes the...
FDA Breakthrough Device using Optical Spectroscopy was Found to Significantly Increase Physicians’ Detection of Skin Cancer
MIAMI--(BUSINESS WIRE)--DermaSensor Inc., the pioneer of the first point-and-click skin cancer detection device for primary care physicians, announces the publication...
FDA Breakthrough Device using Optical Spectroscopy was Found to Significantly Increase Physicians’ Detection of Skin Cancer
MIAMI--(BUSINESS WIRE)--DermaSensor Inc., the pioneer of the first point-and-click skin cancer detection device for primary care physicians, announces the publication...
BioHarvest Sciences Announces Major Product Launch of VINIA-Based Functional Coffees
VINIA Superfood Coffee will be a unique disruptor in the $6B US coffee pod marketFirst of three Major "VINIA Inside"...
SELLAS to Host Corporate Update Webinar on January 3, 2024 at 8:30 am ET
NEW YORK, Dec. 13, 2023 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a...
Protagonist Earns $10 Million Payment for Achievement of Clinical Milestone in Phase 2b ANTHEM-UC Study of JNJ-2113 in Adults with Moderately to Severely Active Ulcerative Colitis
NEWARK, CA / ACCESSWIRE / December 13, 2023 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced it has...
Research for the Treatment of a ‘Black Sheep’ Cancer Moves to Human Clinical Trials
With $3.5 million in funding from the GI Research Foundation, a team at the MD Anderson Cancer Center explores a...
Quoin Pharmaceuticals Announces FDA Clearance of Clinical Optimization Plan for QRX003 for Netherton Syndrome
Positive initial data and clean safety profile catalyze optimization planSize of both ongoing clinical trials significantly increasedLower dose eliminated from...
Kineta Publishes Preclinical Data Demonstrating the Potential of Anti-VISTA Antibody KVA12123 as an Immunomodulatory Therapy for Cancer
VISTA Blocking KVA12123 Monoclonal Antibody (mAb) Engineered to Provide Strong Single Agent Anti-Tumor Activity While Minimizing Cytokine Related Adverse Events...
Preventogen is a New Tool in the Fight Against Antibiotic-Resistant Infections Caused by Superbugs, a Leading Cause of Death Worldwide
Preventogen's FDA-Cleared Microbicidal Liquid Polymer Ensures the Eradication of These Dangerous Pathogens on Contact While Forming a More Effective and...
“Stemtech’s Annual Incentive Cruise Sets Sail With Top Earners on Board; Colombia Pre-Registration Now Open and Product Expansion Unveiled for Ecuador”
Before the REORGANIZATION, Stemtech thrived IN COLOMBIA, generating $10 million and boasting 3,000 IBPs in the Colombian market.NAPLES, FL /...
Ainos, Inc. Announces Stock Consolidation
SAN DIEGO, CA / ACCESSWIRE / December 12, 2023 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos," or the "Company"), a diversified...
ASLAN Pharmaceuticals Provides Year-End Update on Its Eblasakimab and Farudodstat Programs
Following the successful TREK-AD Phase 2b study of eblasakimab in moderate-to-severe atopic dermatitis, process is underway to identify potential partners....